EGFR and cancer: EGFR, human epidermal growth factor receptor 2 (HER2) and HER3 are frequently overexpressed in human cancers and have been shown to induce canonical cancer-associated signals upon their activation by mutation, gene amplification or constitutive ligand presentation [1, 4].